As the FDA investigates China-made plastic syringes because of compatibility issues with syringe pumps, Cardinal Health said 32 million of its syringes are experiencing the same issue.
Category: Supply Chain
Red Cross declares blood shortage as number of donors dips to 20 year low
The number of blood donors in the U.S. has hit a 20-year low, the American Red Cross warned Jan. 9.
US facing 'emergency' blood shortage
The American Red Cross said the U.S. is experiencing an “emergency” blood shortage as the number of donors has hit a 20-year low.
HCA's GPO secured 20 health system partners in 2023
HCA Healthcare’s group purchasing organization, HealthTrust Performance Group, signed 20 new health system and hospital partners in 2023, increasing its roster of exclusive partnerships to 58.
Thousands of devices have not been tested for safety — but were FDA approved
Most medical devices, including many implants, are being cleared for sale by the FDA without tests for safety or effectiveness, KFF Health News reported Dec. 21.
Pharmaceutical companies to hike prices of 500 drugs
Large drugmakers including Pfizer and Takeda Pharmaceuticals plan to raise prices of more than 500 prescription drugs this month, according to research cited by Reuters.
Northwell targets medical waste
Northwell Health plans to annually treat more than 500,000 pounds of regulated medical waste in its core laboratory, which processes samples from more than 20,000 patients every day.
$123M nitrile glove plant in stasis after temporary shortage
The federal government paid $123 million to build the nation’s first plant to reproduce synthetic rubber into nitrile gloves, but after medical supply shortages ebbed, the Virginia facility sits unused, The Washington Post reported Dec. 28.
NYC Health + Hospitals to create supplier diversity council
NYC Health + Hospitals’ Danielle DiBari, PharmD, and the system’s supply team are working to establish a Diverse Supplier Council to cement equity throughout the hospital supply chain.
Philips recalls MRI devices due to explosion risks
Philips North America is recalling 150 MRI devices in the U.S. due to explosion risks. The FDA has classified the recall as a Class 1, the most serious type of recall.
